Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 22Terminated 4Active not recruiting 3

Sponsor Class

OTHER 9NETWORK 4NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 2Genitourinary 2

Conditions

Urinary Bladder Neoplasms 2Lymphoma 2Hodgkin Disease 2

Interventions

Radiotherapy 41Cisplatin 36Fluorouracil 17Paclitaxel 15Docetaxel 14Cyclophosphamide 14Carboplatin 14Filgrastim 13Doxorubicin 13Gemcitabine 11Etoposide 11Capecitabine 10Surgical Procedures, Operative 9Methotrexate 9Leucovorin 9Chemotherapy, Adjuvant 9Vincristine 8Peripheral Blood Stem Cell Transplantation 8Oxaliplatin 8Dexamethasone 7Bevacizumab 7Topotecan 6Radiotherapy, Conformal 6Prednisone 6Fenretinide 6Cetuximab 6Neoadjuvant Therapy 5Mitomycin 5Irinotecan 5Ifosfamide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × NETWORK × Vinblastine × Clear all
NCT01390584 2023-06-29

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Terminated
6 enrolled 9 charts
Lymphoid

Hodgkin Disease, Lymphoma

NCT00005047 2017-06-08

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

SWOG Cancer Research Network

Phase 3 Terminated
521 enrolled 18 charts
Genitourinary

Urinary Bladder Neoplasms

NCT00005090 2013-01-24

S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease

SWOG Cancer Research Network

Phase 3 Terminated
11 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00003640 2012-03-06

Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
73 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡